Literature DB >> 912660

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.

J L Hayward, P P Carbone, J C Heuson, S Kumaoka, A Segaloff, R D Rubens.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 912660     DOI： 10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  154 in total

1.  Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.

Authors:  E H Koh; A U Buzdar; F C Ames; S E Singletary; M D McNeese; D Frye; F A Holmes; G Fraschini; V Hug; R L Theriault
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Primary Endocrine Therapy for Locally Advanced Breast Cancer-Is it an Inferior Approach? Experience from Nottingham.

Authors:  Radhika Lakshmanan; Kwok Leung Cheung
Journal:  Indian J Surg Oncol       Date:  2010-12-30

3.  Poor response of breast cancer to tamoxifen.

Authors:  P J McDonald; R Carpenter; G T Royle; I Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 4.  Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations.

Authors:  A D Stockdale; A Y Rostom
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

Review 5.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

6.  Histochemical demonstration of endogenous estrogen in breast carcinomas: biochemical and clinical correlation.

Authors:  I Katayama; M Shimizu; M Miura; M Maruyama; M Kobayashi; Y Iino; M Izuo; S Wakatsuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

7.  Selection of high risk groups among prognostically favorable patients with breast cancer.

Authors:  J A Andersen; K Fischermann; K Hou-Jensen; E Henriksen; K W Andersen; H Johansen; H Brincker; H T Mouridsen; T Castberg; N Rossing; M Rørth
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

8.  Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.

Authors:  A Sulkes; E Gez; M R Pfeffer; R Catane; R Isacson; S Biran
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.

Authors:  H T Mouridsen; M Cornbleet; R Stuart-Harris; I Smith; R Coleman; R Rubens; M McDonald; H Rainer; A van Oosterom; J Smyth
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

10.  Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.

Authors:  G Francini; R Petrioli; A Aquino; S Gonnelli
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.